Midgard Science

Labs / Protein production

Biomay AG

Vienna, Austria · biomay.com

GMP

Biomay AG is a biopharmaceutical CDMO in Vienna, Austria. It manufactures GMP-grade plasmid DNA, mRNA, recombinant proteins, and related drug products for clinical phases I–III and market supply. The company operates two GMP manufacturing sites in Vienna.

They take quote requests through a form on their website with project details. Their quote form

What they offer

  • Vector development

    Develops vectors for plasmids, proteins, and mRNA.

  • GMP cell banking

    Creates Master Cell Banks and Working Cell Banks.

  • Process development and feasibility studies

    Carries out process development and feasibility work for client projects.

  • Analytical development / quality control methods

    Develops analytical methods and quality control methods for project support.

  • GMP manufacturing of bulk drug substance

    Manufactures bulk drug substance for clinical phases I–III and market supply.

  • GMP aseptic filling of drug product

    Performs aseptic filling of drug product for clinical phases I–III.

  • Quality control and Qualified Person release

    Provides quality control and QP release services.

  • Analytical method and process validation (PPQ)

    Supports analytical method validation and process validation activities.

  • Regulatory support

    Provides regulatory support for client programs.

  • ICH stability testing & long-term storage

    Conducts ICH stability testing and long-term storage.

  • Aseptic filling

    Offers cGMP fill & finish services for DNA, proteins, and RNA.

  • Personalized manufacturing

    Manufactures patient-specific DNA and mRNA cancer vaccines within a few weeks.

What they work on

Modalities
mRNA, Viral vector, Gene editing, Recombinant protein, Vaccine, Plasmid DNA, LNP / formulation
Species and models
E. coli
Assays and studies
analytical development, quality control, qualified person release, analytical method validation, process validation, ICH stability testing, in-house rapid sterility testing, assay development
Instruments and platforms
automated filling / stoppering line, high-pressure homogenizers, centrifuges, process chromatography equipment
Scale and capacity
two GMP manufacturing sites, 10 segregated GMP clean room suites, total floor space 6000 sqm / 60,000 sq ft, headquarter facility 4000 sqm total floor space, mRNA Competence Center 2000 sqm total floor space, bioreactor capacities: 30L, 50L, 150L, 750L, personalized bioreactor capacities: 4 x 3L, capacity up to 1500 2R glass vials per batch, up to 1500 sterile-filled vials per batch, up to 50 mg mRNA per patient, up to 300 mg DNA per patient
Therapeutic areas
cancer immunotherapy, gene editing, ATMPs
Turnaround
within a couple of weeks · from incoming of starting material to released mRNA-LNP in three weeks · from incoming of starting material to released plasmid DNA in two weeks · personalized DNA cancer vaccines in as little as two weeks · mRNA-based vaccines in approximately three weeks
What to send
In-silico sequence of individual patient mRNA provided by sponsor · DNA fragment synthesis as starting material (external) · In-silico sequence of individual patient DNA provided by sponsor
Type
CDMO
Sites
Vienna, Austria · Vienna 1220 (Aspern Seestadt), Austria · Vienna 1090, Austria
Quality
GMP (plasmid DNA, mRNA, recombinant proteins, aseptic filling, personalized batches) · cGMP (fill & finish services for DNA, proteins, and RNA) · ICH and EMA directives (2001/83/EC, 2001 · FDA inspected (company facilities) · FDA-grade (CRISPR/Cas9 nuclease)
Serves
North America
Address
Ada-Lovelace-Straße 2; 1220 Vienna, Austria
Founded
1984

Public records

Ownership
BIOMAY AG · AT GLEIF

Similar labs. Artis, Crystal NAX, Rose BioSolutions, Miltenyi Bioindustry

Found in a contract services directory. Listing built from biomay.com. Work here? Claim this listing.

Biomay AG · Midgard Science